IBDEI0V4 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15349,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,15349,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,15349,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,15350,0)
 ;;=V15.89^^89^905^46
 ;;^UTILITY(U,$J,358.3,15350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15350,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,15350,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,15350,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,15351,0)
 ;;=V11.3^^89^905^25
 ;;^UTILITY(U,$J,358.3,15351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15351,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,15351,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,15351,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,15352,0)
 ;;=V15.07^^89^905^26
 ;;^UTILITY(U,$J,358.3,15352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15352,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,15352,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,15352,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,15353,0)
 ;;=V13.4^^89^905^27
 ;;^UTILITY(U,$J,358.3,15353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15353,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,15353,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,15353,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,15354,0)
 ;;=V12.72^^89^905^31
 ;;^UTILITY(U,$J,358.3,15354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15354,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,15354,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;^UTILITY(U,$J,358.3,15354,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,15355,0)
 ;;=V12.59^^89^905^30
 ;;^UTILITY(U,$J,358.3,15355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15355,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,15355,1,5,0)
 ;;=5^Hx of CHF
 ;;^UTILITY(U,$J,358.3,15355,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,15356,0)
 ;;=V45.81^^89^905^29
 ;;^UTILITY(U,$J,358.3,15356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15356,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,15356,1,5,0)
 ;;=5^Hx of CABG
 ;;^UTILITY(U,$J,358.3,15356,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,15357,0)
 ;;=V15.84^^89^905^28
 ;;^UTILITY(U,$J,358.3,15357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15357,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,15357,1,5,0)
 ;;=5^Hx of Asbestos Exposure
 ;;^UTILITY(U,$J,358.3,15357,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,15358,0)
 ;;=V15.85^^89^905^47
 ;;^UTILITY(U,$J,358.3,15358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15358,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,15358,1,5,0)
 ;;=5^Hx of Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,15358,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,15359,0)
 ;;=V10.72^^89^905^34
 ;;^UTILITY(U,$J,358.3,15359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15359,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,15359,1,5,0)
 ;;=5^Hx of Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,15359,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,15360,0)
 ;;=V15.3^^89^905^35
 ;;^UTILITY(U,$J,358.3,15360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15360,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,15360,1,5,0)
 ;;=5^Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,15360,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,15361,0)
 ;;=V10.61^^89^905^37
 ;;^UTILITY(U,$J,358.3,15361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15361,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,15361,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,15361,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,15362,0)
 ;;=V12.03^^89^905^39
 ;;^UTILITY(U,$J,358.3,15362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15362,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,15362,1,5,0)
 ;;=5^Hx of Malaria
